1. Home
  2. SFNC vs TLX Comparison

SFNC vs TLX Comparison

Compare SFNC & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Simmons First National Corporation

SFNC

Simmons First National Corporation

HOLD

Current Price

$19.28

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$7.82

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFNC
TLX
Founded
1903
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SFNC
TLX
Price
$19.28
$7.82
Analyst Decision
Buy
Strong Buy
Analyst Count
4
4
Target Price
$22.75
$21.00
AVG Volume (30 Days)
1.1M
151.6K
Earning Date
01-20-2026
01-15-2026
Dividend Yield
4.41%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.04
Revenue
N/A
$664,225,558.00
Revenue This Year
$27.12
N/A
Revenue Next Year
$7.58
N/A
P/E Ratio
N/A
$244.50
Revenue Growth
N/A
55.35
52 Week Low
$17.00
$7.72
52 Week High
$23.44
$30.36

Technical Indicators

Market Signals
Indicator
SFNC
TLX
Relative Strength Index (RSI) 56.93 27.23
Support Level $19.01 $7.72
Resistance Level $19.83 $10.03
Average True Range (ATR) 0.41 0.27
MACD 0.04 -0.18
Stochastic Oscillator 52.86 4.33

Price Performance

Historical Comparison
SFNC
TLX

About SFNC Simmons First National Corporation

Simmons First National Corp is a financial holding company. The company through its subsidiaries is engaged in providing banking services including consumer, real estate and commercial loans, checking, savings and time deposits. The company's loan portfolio comprises construction, single-family residential and commercial loans; non-real estate loans, nonaccrual and past due loans; and credit card loans, student loans and other consumer loans. It also offers various products and services such as trust services, investments, agricultural finance lending, equipment lending, insurance, consumer finance and small business administration lending. The business activity of the firm is functioned through the region of the United States.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: